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        Control of cell proliferation is fundamental 
to the development of multicellular organisms. 
Regulation of total cell mass during develop-
ment is dependent on termination of cell pro-
liferation at the appropriate time as well as on 
the initial stimulation of such proliferation (  1  ). 
In most vertebrate cell lineages, for example, 
precursor cells divide a limited number of times 
before they stop and undergo terminal diff  er-
entiation into specialized postmitotic cells. 
However, the mechanisms responsible for spatio-
temporal regulation of the cell cycle during 
  development have remained largely unclear. In 
particular, the mechanisms that control the exit 
of cells from the cell cycle during diff  erentia-
tion of the various cell lineages are not known. 
  The basic helix-loop-helix transcription fac-
tor c-Myc is a key regulator of exit from and re-
entry into the cell cycle. The observations that 
ectopic expression of c-Myc alone is suffi   cient to 
promote the reentry of quiescent cells into the 
cell cycle in the absence of serum mitogens (  2  ) 
and that the level of endogenous c-Myc ex-
pression is high at the G  0  -G  1   transition, low in 
proliferating cells, and undetectable in most 
resting cells (  3  ) are consistent with the hypothesis 
that c-Myc controls the decision of whether to 
divide or not in mammalian cells. Overexpression 
of c-Myc is also implicated in the development of 
diverse human tumors. 
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  Cell proliferation is strictly controlled during differentiation. In T cell development, the cell 
cycle is normally arrested at the CD4  +  CD8  +   stage, but the mechanism underlying such 
differentiation-specifi  c exit from the cell cycle has been unclear. Fbxw7 (also known as 
Fbw7, Sel-10, hCdc4, or hAgo), an F-box protein subunit of an SCF-type ubiquitin ligase 
complex, induces the degradation of positive regulators of the cell cycle, such as c-Myc, 
c-Jun, cyclin E, and Notch.   FBXW7   is often mutated in a subset of human cancers. We 
have now achieved conditional inactivation of   Fbxw7   in the T cell lineage of mice and 
found that the cell cycle is not arrested at the CD4  +  CD8  +   stage in the homozygous mutant 
animals. The mutant mice manifested thymic hyperplasia as a result of c-Myc accumulation 
and eventually developed thymic lymphoma. In contrast, mature T cells of the mutant mice 
failed to proliferate in response to mitogenic stimulation and underwent apoptosis in 
association with accumulation of c-Myc and p53. These latter abnormalities were corrected 
by deletion of   p53  . Our results suggest that Fbxw7 regulates the cell cycle in a differentia-
tion-dependent manner, with its loss resulting in c-Myc accumulation that leads to hyper-
proliferation in immature T cells but to p53-dependent cell-cycle arrest and apoptosis in 
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T cells induced expression of p53, which in turn led to cell-
cycle arrest and apoptosis. We therefore conclude that Fbxw7 
is required for the regulation of c-Myc abundance and for 
cell-cycle exit in immature T cells but for the activation of 
proliferation in mature T cells. We propose that Fbxw7 is a key 
regulator that determines the fate of cells to divide or not to 
divide by targeting c-Myc for degradation. 
    RESULTS   
  Conditional inactivation of   Fbxw7   in the T cell lineage 
  To investigate the mechanisms underlying cell-cycle exit 
during diff  erentiation, we took advantage of several aspects of 
T cell development, including the existence of many well-
characterized diff  erentiation markers, the coincidence of cell-
cycle exit and reentry with clearly defi  ned developmental stages, 
and the fact that, given the nonessential nature of T cells for 
survival, mice are not killed by genetic manipulation of these 
cells. The increased abundance of Fbxw7 messenger RNA 
(mRNA) at the DP stage of T cell development (  Fig. 1 A  ) led 
us to hypothesize that Fbxw7 might contribute to the cell-cycle 
exit that normally occurs at this stage.   
  We established mouse embryonic stem (ES) cells that 
harbor a   “  fl  oxed  ”     Fbxw7   allele in which exon 5 (which en-
codes the F-box domain) is fl  anked by loxP sites. This allele 
was generated by homologous recombination and transient 
transfection of the cells with a vector for Cre recombinase to 
remove the introduced   neo   cassette (  Fig. 1 B  ). Mice harbor-
ing the fl  oxed allele were produced by microinjection of the 
mutant ES cells into blastocysts and breeding of the resultant 
chimeric animals with mice of the C57BL/6 strain (  Fig. 1 C  ). 
Mice homozygous for the fl  oxed   Fbxw7   allele (  Fbxw7  F/F    ) had 
no apparent defects, indicating that the allele is fully functional. 
Mice homozygous for germline deletion of exon 5 of   Fbxw7   
(  Fbxw7      E5/    E5    ) died in utero (of 61 live-born off  spring of 
  Fbxw7  +/    E5     intercrosses, 18 were  Fbxw7  +/+    , 43 were  Fbxw7  +/    E5    , 
and 0 were   Fbxw7      E5/    E5    ) and were indistinguishable from 
the   Fbxw7    –  /  –      mice that we previously described (  10  ), indicat-
ing that deletion of exon 5 abolishes the function of   Fbxw7  . To 
ablate   Fbxw7   only in the T cell lineage, we crossed   Fbxw7  F/F     
mice with mice harboring a   Cre   transgene under the control of 
the promoter for the Lck or CD4 gene (Lck-Cre or CD4-Cre). 
We confi  rmed that almost all fl  oxed alleles were inactivated 
by Cre in thymocytes of the resulting off  spring (  Fig. 1 D   
and Fig. S1, available at http://www.jem.org/cgi/content/
full/jem.20062299/DC1). 
  The cell cycle is not arrested in Fbxw7-defi  cient DP cells 
  The thymus of Lck-Cre/  Fbxw7  F/F     mice was larger than that 
of control (Lck-Cre/  Fbxw7  +/F    ) mice (  Fig. 2 A  ).   Flow cyto-
metric analysis also revealed that both the percentage (  Fig. 2 B  ) 
and absolute number (  Fig. 2 C  ) of DP thymocytes were in-
creased in Lck-Cre/  Fbxw7  F/F     mice compared with littermate 
controls, whereas the absolute numbers of DN, CD4 SP, and 
CD8 SP thymocytes did not diff  er between the two geno-
types. The number of DP thymocytes was also increased in 
CD4-Cre/  Fbxw7  F/F     mice, albeit to a lesser extent than in 
  Regulation of the abundance of c-Myc is achieved at 
several levels, one of which is control of c-Myc stability medi-
ated by posttranslational modifi  cation. We and others have 
shown that the F-box protein Fbxw7 (also known as Fbw7, 
Sel-10, hCdc4, or hAgo), the substrate-recognition subunit of 
an SCF-type ubiquitin ligase complex, interacts with and me-
diates the ubiquitylation of c-Myc in a manner dependent on 
its phosphorylation on Thr  58   (  4, 5  ). Mutation of this residue is 
common in many human malignancies and results in marked 
stabilization of c-Myc (  6, 7  ). Accumulation of c-Myc is also 
apparent in mouse   Fbxw7    –  /  –      cells (  4  ), as well as in lymphomas 
that arise in   Fbxw7  +/  –      mice (  8  ). These data suggest that Fbxw7 
is a negative regulator of c-Myc abundance and may thereby 
induce exit of cells from the cell cycle (  9  ). 
  To investigate the role of Fbxw7-mediated ubiquitylation 
in control of the cell cycle during development in a physio-
logically relevant manner, we and others have generated mice 
that are defi  cient in Fbxw7. However, the   Fbxw7    –  /  –      embryos 
die in utero at embryonic day 10.5, manifesting marked ab-
normalities in vascular development as a result of dysregulation 
of Notch signaling (  10, 11  ). This early embryonic mortality 
has thus impeded study of the role of Fbxw7 in cell-cycle 
control. To overcome this obstacle, we have generated mice 
with   Fbxw7   conditionally ablated only in the T cell lineage, 
in which cell proliferation and diff  erentiation have been ex-
tensively characterized. 
  T cell progenitors are produced in the bone marrow, un-
dergo maturation in the thymus, and fi  nally populate the 
peripheral lymphoid organs. In the thymus, most immature T 
cells initially express neither CD4 nor CD8 and are therefore 
referred to as double-negative (DN) cells (  12  ). Maturation of 
DN cells to cells that express both CD4 and CD8 (double-
positive [DP] cells) requires a sequence of events that are closely 
associated with rearrangement of the TCR. DP cells diff  eren-
tiate into single-positive (SP) T cells that express either CD4 
or CD8. SP T cells exit the thymus and are routed to periph-
eral lymphoid organs, such as the spleen and lymph nodes, where 
they participate in a variety of immune responses. Early DN cells 
remain in G  0   phase of the cell cycle. Extensive proliferation 
normally occurs within the CD25    −   CD44    −    (stage IV) popula-
tion of DN cells, resulting in a several hundredfold increase 
in cell number. The cell cycle is rapidly restrained, however, 
when T cells become DP, and SP cells in the peripheral lym-
phoid organs remain in G  0   phase for long periods until they 
encounter cognate antigen bound at the surface of an anti-
gen-presenting cell. Such activation by antigen induces ex-
tensive proliferation of peripheral SP T cells, most of which 
are subsequently destined to die. 
  We now show that the loss of Fbxw7 in immature T cells 
of mice results in their failure to exit the cell cycle at the DP 
stage, leading to thymic hyperplasia and the subsequent de-
velopment of lymphoma. Among known targets of Fbxw7, 
only c-Myc and Notch accumulated in the Fbxw7-defi  cient 
thymocytes, and Notch did not appear to contribute to the 
hyperproliferation phenotype. In contrast to immature T cells, 
the accumulation of c-Myc apparent in Fbxw7-null mature JEM VOL. 204, November 26, 2007 
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full/jem.20062299/DC1). We therefore measured the incor-
poration of BrdU into thymocytes 3 h after its intraperitoneal 
administration. The extent of BrdU incorporation into total 
thymocytes of Lck-Cre/  Fbxw7  F/F     mice was about twice that 
into those of control mice (  Fig. 2 D  ). Although incorpora-
tion of BrdU into DN thymocytes did not diff  er between 
Lck-Cre/  Fbxw7  F/F     and control mice, incorporation of BrdU 
into DP thymocytes was markedly greater for Lck-Cre/
  Fbxw7  F/F     mice. The incorporation of BrdU into CD4 SP cells 
did not diff  er substantially between the two genotypes. 
Lck-Cre/  Fbxw7  F/F     mice (see   Fig. 3 B  ). It is possible that the 
onset of cell-cycle arrest induced by Fbxw7 occurs slightly 
earlier than that of expression of CD4. 
  The size of the thymic cell population is largely depen-
dent on the extents of apoptosis and proliferation during dif-
ferentiation. Susceptibility to spontaneous apoptosis or to that 
induced by antibodies to anti-CD3 or dexamethasone was de-
termined in vitro by propidium iodide staining and was found 
to be largely unaff  ected in thymocytes from Lck-Cre/  Fbxw7  F/F     
mice (Fig. S2, available at http://www.jem.org/cgi/content/
  Figure 1.     Generation of mice with T cell  –  specifi  c defi  ciency of Fbxw7. (A) RT and real-time PCR analysis of the relative abundance of Fbxw7 
mRNA in DN, DP, CD4 SP, and CD8 SP mouse thymocytes isolated by fl  ow cytometry. Data are means   ±   SD of values from three independent experiments. 
(B) Schematic representations of the wild-type mouse   Fbxw7   allele, the targeting vector, the   Fbxw7   allele with a loxP-  neo   cassette (Flox-neo), the fl  oxed 
  Fbxw7   allele (Flox), and the fl  oxed   Fbxw7   allele after removal of exon 5 by Cre recombinase (    E5). The expected sizes of bands in a Southern blot analysis 
with probe 1 (for StuI [S] fragments) or probe 2 (for BamHI [B] fragments) are indicated. Exons are shown as numbered closed boxes, and loxP sites are 
shown as closed triangles. (C) Southern blot analysis with probe 2 of BamHI-digested DNA from the tail of mice of the indicated genotypes. The wild-type 
and fl  oxed alleles give rise to hybridizing fragments of 7.8 and 1.2 kb, respectively. (D) PCR analysis of genomic DNA from the thymus of   Fbxw7  F/F  ,  Lck-
Cre/  Fbxw7  +/F   , and Lck-Cre/  Fbxw7  F/F    mice with the primers Floxed 1 and Floxed 2 (see Materials and methods). The positions of amplifi  ed fragments cor-
responding to wild-type, fl  oxed, and     E5 alleles are indicated.     2878 FAILURE OF CELL-CYCLE EXIT IN   FBXW7   − / −     THYMOCYTES | Onoyama et al.
for exit from the cell cycle at the DP stage. However, the cell 
cycle appeared to be arrested at the SP stage even in the ab-
sence of Fbxw7, suggesting that the requirement for Fbxw7 
in cell-cycle arrest changes between the DP and SP stages, 
probably as a result of positive selection (see Discussion). 
The incorporation of BrdU into CD8 SP cells was much greater 
than that into CD4 SP cells for both genotypes and was highly 
variable among individuals (unpublished data), probably because 
this fraction contains both immature SP cells and mature CD8 
SP cells. These data indicated that Fbxw7 is indispensable 
  Figure 2.     Failure of cell-cycle arrest in DP thymocytes of Lck-Cre/        Fbxw7  F/F              mice. (A) Gross appearance of the thymus of Lck-Cre/  Fbxw7  +/F    and 
Lck-Cre/  Fbxw7  F/F    mice at 8 wk of age. Bar, 5 mm. (B) Representative fl  ow cytometric analysis of surface expression of CD4 and CD8 on thymocytes from 
Lck-Cre/  Fbxw7  +/F    or  Lck-Cre/ Fbxw7  F/F    mice at 8 wk of age. The percentages of DN, DP, and SP populations are indicated. (C) Absolute cell numbers for total 
thymocytes and thymocyte subsets determined as in B. Data are means   ±   SD of values from 13   Fbxw7  F/F    (control) and 19 Lck-Cre/  Fbxw7  F/F    mice. **, P   <   0.01 
using the Student  ’  s   t   test. (D) BrdU incorporation into thymocytes in vivo. The proportion of each thymocyte subset in S phase was determined by 
measurement of incorporation of BrdU after its intraperitoneal injection in 8-wk-old Lck-Cre/  Fbxw7  F/F    or   Fbxw7  F/F    (control) mice. Data are means   ±   SD of 
values from four animals of each genotype. **, P   <   0.01 using the Student  ’  s   t   test. (E) Increased expression of Notch1, Notch3, and c-Myc in total thymo-
cytes from Lck-Cre/  Fbxw7  F/F    mice. Total thymocytes of 8-wk-old Lck-Cre/  Fbxw7  +/F    or  Lck-Cre/ Fbxw7  F/F    mice were subjected to immunoblot analysis with 
antibodies to the indicated proteins. (F) Accumulation of Notch1, Notch3, and c-Myc specifi  cally in DP thymocytes of Lck-Cre/  Fbxw7  F/F    mice.  Thymocyte 
subsets of   Fbxw7  F/F    (control) or Lck-Cre/  Fbxw7  F/F    mice were analyzed as in E.     JEM VOL. 204, November 26, 2007 
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the DP subset of Lck-Cre/  Fbxw7  F/F     mice. The half-lives 
of Notch1, Notch3, and c-Myc in the DP subset of Lck-
Cre/  Fbxw7  F/F     mice were also increased compared with 
those in control mice (Fig. S3, available at http://www
.jem.org/cgi/content/full/jem.20062299/DC1). The levels of 
cyclin E and phosphorylated c-Jun were not aff  ected by
deletion of   Fbxw7  , suggesting that the abnormal accumulation 
of Notch or c-Myc (or of other unknown targets of Fbxw7) 
  c-Myc (not Notch) is responsible for overproliferation 
of Fbxw7-null DP cells 
  With the use of immunoblot analysis, we next examined 
the expression of substrates of Fbxw7, including cyclin E, 
c-Myc, Notch1, Notch3, and c-Jun, in total thymocytes (  Fig. 
2 E  ) as well as in thymocyte subsets (  Fig. 2 F  ) of Lck-Cre/
  Fbxw7  F/F     or control mice. The amounts of Notch1, Notch3, 
and c-Myc were increased in total thymocytes as well as in 
  Figure 3.     c-Myc is responsible for the overproliferation phenotype of Fbxw7-defi  cient DP thymocytes. (A) Representative fl  ow cytometric 
analysis of surface expression of CD4 and CD8 on thymocytes from   Fbxw7  F/F  / RBP-J  F/F    (control),  CD4-Cre/ Fbxw7  F/F  ,  CD4-Cre/ Fbxw7  F/F  / RBP-J  F/F  ,  or  CD4-Cre/
  Fbxw7  F/F  / c-Myc  F/F    mice at 12 wk of age. The respective percentages are indicated. (B) Absolute cell numbers for total thymocytes and thymocyte subsets 
determined as in A. Data are means   ±   SD of values from 7   Fbxw7  F/F  / RBP-J  F/F    (control), 11 CD4-Cre/  Fbxw7  F/F   , 6 CD4-Cre/  Fbxw7  F/F  / RBP-J  F/F   , and 5 CD4-Cre/
  Fbxw7  F/F  / c-Myc  F/F    mice. *, P   <   0.05 using the Student  ’  s   t   test.   2880 FAILURE OF CELL-CYCLE EXIT IN   FBXW7   − / −     THYMOCYTES | Onoyama et al.
expression (Fig. S4 B). Southern blot analysis confi  rmed that 
the clonality of tumor cells in the recipient animals was al-
most identical to that of the original thymoma (Fig. S4 C). 
These results thus indicated that the lymphomas of the mu-
tant mice are capable of lymphomatogenesis in nude mice. 
  These lymphomas were fatal. Specifi  cally, 12 out of 23 
Lck-Cre/  Fbxw7  F/F     mice developed tumors, and these animals 
either died or became terminally ill (and were killed) be-
tween 14 and 60 wk of age (  Fig. 4 I  ). There were no marked 
diff  erences in gross appearance, surface expression of CD4 or 
CD8, or histopathologic characteristics between early-onset 
(  <  20 wk of age) and late-onset (  >  20 wk of age) tumors 
(Fig. S5, available at http://www.jem.org/cgi/content/full/
jem.20062299/DC1). We bred Lck-Cre/  Fbxw7  F/F     mice with 
  p53    –  /  –      mice to generate Lck-Cre/  Fbxw7  F/F    /  p53    –  /  –      mice. The 
double-mutant mice developed thymic lymphomas at a mark-
edly increased frequency and with a reduced latency com-
pared with both parental groups (  Fig. 4 I  ). However, there were 
no substantial diff  erences in gross appearance or in surface ex-
pression of CD4 or CD8 between tumors arising in Lck-Cre/
  Fbxw7  F/F     mice and those in Lck-Cre/  Fbxw7  F/F    /  p53    –  /  –      mice 
(Fig. S6). All tumors in mice of both genotypes showed a DP 
phenotype; no SP lymphomas were observed. 
  Fbxw7-defi  cient mature T cells fail to proliferate 
in response to antigenic stimulation 
  Expansion of the DP population did not result in an increase 
in the numbers of SP thymocytes in Fbxw7-defi  cient mice, 
suggesting that the DP thymocytes had lost the ability to un-
dergo positive selection or that the proliferation or survival of 
SP cells was impaired. The percentages and numbers of CD4  +   
or CD8  +   T cells were markedly reduced, whereas the num-
ber of B cells was unaff  ected, in the peripheral lymphoid or-
gans, such as the spleen and lymph nodes, of Lck-Cre/ Fbxw7  F/F     
mice (  Fig. 5, A and B  ; unpublished data).   To investigate the 
mechanism underlying this defi  ciency of mature T cells, we 
measured the incorporation of [  3  H]thymidine into splenic T 
cells in response to mitogenic stimulation. Fbxw7-defi  cient 
T cells did not respond to stimulation with either anti-CD3 
or the combination of phorbol 12,13-dibutyrate and iono-
mycin, whereas these agents stimulated the proliferation of 
control T cells in a concentration-dependent manner (  Fig. 5 C  ). 
To exclude the possibility that TCR signaling was impaired 
in the Fbxw7-defi  cient splenic T cells, we fi  rst examined the 
induction of the early activation marker CD69 in response to 
stimulation with anti-CD3. The induction of CD69 expression 
was similar in Fbxw7-null and control T cells ( Fig. 5 D ). Further-
more, phosphorylation of Lck, extracellular signal-regulated 
kinase (ERK), and c-Jun N-terminal kinase (JNK) in re-
sponse to TCR activation was not altered in Fbxw7-null T 
cells (  Fig. 5 E  ). These results thus excluded the possibility of 
a signaling defect in Fbxw7-null T cells. Fbxw7 thus appeared 
to be indispensable for the proliferation of mature T cells in 
response to mitogenic stimulation, a response that is neces-
sary for maintenance of the T cell population in peripheral 
lymphoid organs. 
may be responsible for promotion of the cell cycle in Fbxw7-
defi  cient DP cells. 
  To determine whether accumulation of Notch or c-Myc 
is responsible for the failure of cell-cycle arrest in Fbxw7-
defi  cient DP thymocytes, we examined the eff  ect of loss of 
Fbxw7 in the absence either of RBP-J, an essential mediator 
of Notch signaling, or of c-Myc. The early inactivation of 
  RBP-J   mediated by Lck-Cre resulted in developmental arrest 
of T cells at the DN stage, whereas its later inactivation medi-
ated by CD4-Cre did not aff  ect the absolute number or the 
production rate of CD4  +   or CD8  +   mature T cells (  13  ). Loss of 
c-Myc also results in developmental arrest of the T cell lin-
eage at the DN stage (  14  ). We therefore generated CD4-Cre/
  Fbxw7  F/F    /  RBP-J  F/F     mice and CD4-Cre/  Fbxw7  F/F    /  c-Myc  F/F     
mice to ablate the RBP-J and c-Myc genes at the DP stage. 
The percentage and absolute number of DP thymocytes in 
CD4-Cre/  Fbxw7  F/F    /  RBP-J  F/F     mice were increased as in CD4-
Cre/  Fbxw7  F/F     mice, whereas those in CD4-Cre/  Fbxw7  F/F    /
  c-Myc  F/F     mice were similar to those in controls (  Fig. 3  ).   These 
genetic data thus suggested that the hyperproliferation pheno-
type of Fbxw7-defi  cient DP thymocytes is dependent on c-Myc 
but not on Notch. We thus concluded that the accumulation of 
c-Myc in Fbxw7-defi  cient DP thymocytes is responsible for 
the failure of cell-cycle exit and the consequent hyperpro-
liferation phenotype. 
  Loss of Fbxw7 in T cells predisposes to thymic lymphoma 
  Lck-Cre/  Fbxw7  F/F     mice developed aggressive lymphomas 
characterized by massive thymic enlargement (  Fig. 4 A  ).   Histo-
pathologic examination of the tumors revealed that the ar-
chitecture of the thymus was completely eff  aced and that 
they contained a uniform population of immature lymphoid 
cells (  Fig. 4, B and C  ), with some areas of necrosis (  Fig. 4 D  ). 
Fat and lung tissue adjacent to the thymus manifested infi  ltra-
tion by tumor cells (  Fig. 4, E and F  ). Flow cytometric analysis 
revealed that the lymphomas typically showed an immature T 
cell immunophenotype characterized by expression of both 
CD4 and CD8 (  Fig. 4 G  ). 
  To examine whether the lymphomas were monoclonal 
in origin, we subjected DNA from two specimens to Southern 
blot analysis with a genomic fragment of the TCR     locus as 
the probe. A single nonrearranged (germline) fragment and 
several prominent rearranged fragments were detected in the 
lymphoma DNA, whereas the wild-type thymic DNA showed 
a smear pattern caused by random rearrangement as well as 
one germline band (  Fig. 4 H  ). These data indicated that the 
lymphomas in Lck-Cre/  Fbxw7  F/F     mice arise by clonal ex-
pansion. Transplantation of 5   ×   10  6   lymphoma cells into the 
peritoneal cavity of nude mice resulted in the development of 
marked ascites, peritoneal lymphadenopathy, extraperitoneal 
invasion of tumor cells, and hepatosplenomegaly after 3 wk 
(Fig. S4 A, available at http://www.jem.org/cgi/content/full/
jem.20062299/DC1). Flow cytometry revealed that both 
the original tumor cells and the tumor cells in the recipient 
nude mice expressed CD4 and CD8, although both types 
of cells exhibited a slight reduction in the level of CD8 JEM VOL. 204, November 26, 2007 
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  Figure 4.     Lck-Cre/    Fbxw7  F/F      mice develop T cell lymphoma. (A) Thymi from   Fbxw7  F/F    (control; left) and Lck-Cre/  Fbxw7  F/F    (middle and right) litter-
mates at 14 wk of age. Those from the Lck-Cre/  Fbxw7  F/F    mice were hyperplastic (middle) or tumorous (right). Bar, 5 mm. (B and C) Hematoxylin-eosin 
staining of sections of the thymus from an   Fbxw7  F/F    mouse (B) or from an Lck-Cre/  Fbxw7  F/F    mouse that developed lymphoma (C). The normal thymic 
structure was destroyed and replaced with large, atypical lymphoma cells in the latter animal. Bars, 50     m. (D) Necrotic lesions in the thymus of an 
Lck-Cre/  Fbxw7  F/F    mouse with lymphoma. Bar, 50     m. (E and F) Infi  ltration of lymphoma cells into the fat (E) and lung (F) of Lck-Cre/  Fbxw7  F/F    mice.  Bars: 
(E) 50     m; (F) 500     m. (G) Surface expression of CD4 and CD8 on thymic lymphoma cells from an Lck-Cre/  Fbxw7  F/F    mouse. (H) Southern blot analysis of 
genomic DNA from the tail and thymus of wild-type mice and from two thymic lymphomas of Lck-Cre/  Fbxw7  F/F    mice. The DNA was digested with BamHI 
and probed with a 2.1-kb EcoRI fragment of the TCR-J    2 locus. The positions of germline and rearranged (arrowheads) fragments are indicated. (I) Kaplan-
Meier plot of the overall survival of mice of the indicated genotypes.     2882 FAILURE OF CELL-CYCLE EXIT IN   FBXW7   − / −     THYMOCYTES | Onoyama et al.
  Loss of Fbxw7 in mature T cells induces p53 expression 
and cell-cycle arrest 
  To explore the mechanism underlying the failure of cell-cycle 
progression in mature T cells of Fbxw7-null mice, we ini-
tially examined the down-regulation of the cyclin-dependent 
  Figure 5.     Proliferative defect of Fbxw7-defi  cient mature T cells. (A) Representative fl  ow cytometric analysis of surface expression of TCR     and 
B220 (top) or of CD4 and CD8 (bottom) on spleen cells from   Fbxw7  F/F    (control) or Lck-Cre/  Fbxw7  F/F    mice at 8 wk of age. The respective percentages are 
indicated. (B) Absolute cell numbers of splenocyte subsets determined as in A. Data are means   ±   SD of values from 8   Fbxw7  F/F    (control) and 14 Lck-Cre/
  Fbxw7  F/F    mice. ***, P   <   0.005 using the Student  ’  s   t   test. (C) Splenic T cells from Lck-Cre/  Fbxw7  +/F    (control) or Lck-Cre/  Fbxw7  F/F    mice were stimulated for 
48 h with the indicated concentrations of anti-CD3     (left) or ionomycin and phorbol 12,13-dibutyrate (PDBu; right), after which the incorporation of 
[  3  H]thymidine was measured. Data are means   ±   SD of values from three independent experiments. (D) Splenic T cells from   Fbxw7  F/F    (control) or Lck-Cre/
  Fbxw7  F/F    mice were left unstimulated (open trace) or stimulated with 5    g/ml  anti-CD3    for 7 h (closed trace) and were then subjected to fl  ow cytometric 
analysis for detection of the early activation antigen CD69. (E) Immunoblot analysis of phospho-Lck and Lck (loading control), phospho-ERK and ERK 
(loading control), and phospho-JNK and JNK (loading control) in splenic T cells from   Fbxw7  F/F    (control) or Lck-Cre/  Fbxw7  F/F    mice at 0, 5, and 10 min after 
stimulation with 5    g/ml  anti-CD3   . The intensity of the bands corresponding to the phosphorylated proteins was normalized by that of total proteins. 
The value at time = 0 is defi  ned as 1.     
kinase inhibitor p27 at the G  0  -G  1   transition. We found that it 
occurred normally in the Fbxw7-defi  cient cells (  Fig. 6 A  ), 
suggesting that the G  0  -G  1   transition was not impaired by 
the lack of Fbxw7.   However, the subsequent expression of 
cyclin A, cyclin E, and Aurora A in these cells was markedly JEM VOL. 204, November 26, 2007 
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increased in the activated T cells of Lck-Cre/  Fbxw7  F/F     
mice (  Fig. 6 C  ). 
  We therefore examined G  1  -S progression in T cells from 
Lck-Cre/  Fbxw7  F/F     mice after antigenic stimulation. Flow cyto-
metric analysis revealed that progression into S phase was in-
hibited and that the proportion of apoptotic cells was increased 
(  Fig. 6, D and E  ). Both the G  1  -S arrest and increased level of 
apoptosis in Fbxw7-defi  cient T cells were reversed by deletion 
inhibited or delayed, which was suggestive of a defect at the 
G  1  -S transition (  Fig. 6 B  ). Abnormal accumulation of c-Myc 
was apparent in the activated mature T cells of Lck-Cre/
  Fbxw7  F/F     mice, as it was in the thymocytes of these animals. 
We also found that the abundance of p53 was increased 
in these cells compared with that in control cells (  Fig. 6 B  ). 
Indeed, the amounts of mRNAs derived from target genes 
of p53, including those for p21, Bax, and Noxa, were also 
  Figure 6.     Abnormal accumulation of c-Myc and induction of p53 in stimulated splenic T cells from Lck-Cre/    Fbxw7          F/F      mice. (A) Immunoblot 
analysis of p27 and Hsp90 (loading control) in splenic T cells from   Fbxw7  F/F    (control) or Lck-Cre/  Fbxw7  F/F    mice at 0, 4, 8, and 12 h after stimulation with 
5    g/ml  anti-CD3   . (B) Immunoblot analysis of cyclin A, cyclin E, Aurora A, c-Myc, p53, and Hsp90 in splenic T cells from   Fbxw7  F/F    (control) or Lck-Cre/
  Fbxw7  F/F    mice at 0, 24, 36, and 48 h after stimulation with 5    g/ml  anti-CD3   . (C) RT and real-time PCR analysis of p53-dependent gene expression in 
splenic T cells from   Fbxw7  F/F    (control) or Lck-Cre/  Fbxw7  F/F    mice after stimulation for 24 h with 5    g/ml  anti-CD3   . Normalized data for p21, Bax, and Noxa 
mRNAs are expressed relative to the corresponding values for cells from control mice and are means   ±   SD of values from three independent experiments. 
(D) Splenic T cells from mice of the indicated genotypes were stimulated with 5    g/ml  anti-CD3    for the indicated times and exposed to BrdU during the 
fi  nal 1 h of incubation. They were then stained with anti-BrdU, and the percentage of BrdU-positive cells was determined by fl  ow cytometry. Data are 
means   ±   SD of values from three independent experiments. (E) Splenic T cells stimulated as in D were stained with propidium iodide, and the percentage 
of sub-G  1   (apoptotic) cells was determined by fl  ow cytometry. Data are means   ±   SD of values from three independent experiments.     2884 FAILURE OF CELL-CYCLE EXIT IN   FBXW7   − / −     THYMOCYTES | Onoyama et al.
this eff  ect (or, albeit less likely, the accumulation of other un-
identifi  ed substrates of Fbxw7) in turn results in opposite phe-
notypes in a manner dependent on developmental stage, such 
as the failure of cell-cycle arrest, leading to tumorigenesis, in 
immature T cells versus the failure of cell-cycle progression 
and induction of apoptosis in mature T cells. This apparent 
discrepancy can be explained by the diff  erence in the eff  ect of 
c-Myc accumulation on the expression of p53, a mediator of 
the checkpoint response to such accumulation. Thus, although 
the abundance of p53 is not increased in immature T cells of 
Lck-Cre/  Fbxw7  F/F     mice, in spite of the accumulation of c-Myc, 
the up-regulation of p53 expression in response to mitogenic 
stimulation is exaggerated in mature T cells of such mice, likely 
as a result of excessive c-Myc accumulation. 
  c-Myc plays a central role in normal cell-cycle progression, 
especially during the transition from G  0   to S phase (  15  ). c-Myc 
is the product of an early response gene, it promotes the entry 
of cells into G  1   phase in response to mitogenic stimulation 
(  16, 17  ), and its expression is maintained throughout the cell 
cycle (  18, 19  ). These observations prompted us to hypothe-
size that c-Myc normally prevents cells from exiting the cell 
cycle, and that Fbxw7-dependent degradation of c-Myc is re-
quired for such exit. During T cell development, the expression 
of   Fbxw7   increases in association with cell-cycle arrest at the 
DP stage. Furthermore, DP thymocytes of Lck-Cre/  Fbxw7  F/F     
mice are defective in cell-cycle arrest and manifest hyperplasia 
and an increased susceptibility to tumorigenesis. These obser-
vations are thus consistent with our hypothesis. 
  The increase in the number of DP thymocytes in Lck-
Cre/  Fbxw7  F/F     mice does not result in an increase in the num-
ber of SP cells. There are at least two possible explanations for 
this observation. First, Fbxw7 may be necessary for effi   cient 
positive selection of thymocytes during the transition from the 
DP to the SP stage. However, positive selection is thought not 
to require cell-cycle progression. Furthermore, our analysis of 
TCR signaling revealed no impairment in Fbxw7-defi  cient 
mice, suggesting that this explanation is unlikely. Second, an 
increase in the level of apoptosis in SP cells of the mutant mice 
might counteract and mask an increase in their generation 
of   p53   (i.e., in cells from Lck-Cre/  Fbxw7  F/F    /  p53    –  /  –      mice). 
These data suggested that abnormal activation of p53, likely 
caused by c-Myc accumulation, is responsible for the growth 
inhibition and induction of apoptosis in mature T cells of 
Lck-Cre/  Fbxw7  F/F     mice. Fbxw7 thus appears to be required 
for maintenance of c-Myc at an appropriate concentration 
and for progression of the cell cycle in response to antigenic 
stimulation in mature T cells. 
  Finally, we compared the extent of p53 induction in re-
sponse to anti-CD3 stimulation between control and Fbxw7-
defi  cient thymocytes and splenic T cells by immunoblot 
analysis. Stimulation with anti-CD3 resulted in similar small 
increases in the abundance of p53 in the mutant and control 
thymocytes (  Fig. 7  ).   In contrast, the up-regulation of p53 
induced by such stimulation was more pronounced in splenic 
T cells than in thymocytes and was markedly greater in splenic 
T cells from the mutant mice than in those from control animals. 
These diff  erences in the induction of p53 between thymocytes 
and splenic T cells from the mutant and control mice appear to 
be refl  ected in the diff  erences in the proliferative character-
istics of these cells. 
    DISCUSSION   
  How an organism regulates cell proliferation during develop-
ment is a central issue in developmental biology. In most 
vertebrate cell lineages, precursor cells divide a limited num-
ber of times before becoming quiescent and undergoing 
terminal diff  erentiation into specialized postmitotic cells (  1  ). 
Characterization of the mechanisms by which cell-cycle reg-
ulators are controlled during this process is important not 
only for our understanding of development but also because 
loss of such control is thought to be a major cause of cancer (  9  ). 
In most tissues, however, how cells exit the cell cycle during 
diff  erentiation has remained largely unknown. Our observa-
tions with conditionally Fbxw7-deficient mice now indi-
cate that Fbxw7 is required for cell-cycle arrest during T 
cell diff  erentiation. 
  We have shown that the loss of Fbxw7 during T cell devel-
opment results in excessive accumulation of c-Myc, and that 
  Figure 7.     Exaggerated induction of p53 in splenic T cells from Lck-Cre/    Fbxw7        F/F    mice. Thymocytes and splenic T cells isolated from   Fbxw7  F/F   
(control) or Lck-Cre/  Fbxw7  F/F    mice were incubated in the absence or presence of 5    g/ml  anti-CD3    for 24 h, after which cell lysates were subjected to 
immunoblot analysis with antibodies to p53 and to Hsp90 (loading control).     JEM VOL. 204, November 26, 2007 
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shown that Lck-Cre/  Fbxw7  F/F     mice manifest spontaneous 
tumorigenesis in the thymus at earlier ages than do Lck-Cre/
  Fbxw7  +/F     mice. This tumor development was further promoted 
by the deletion of   p53  , suggesting that p53 inhibits tumori-
genesis induced by the loss of Fbxw7, although we did not de-
tect induction of p53 expression in Fbxw7-null thymocytes. 
The low level of p53 expression in these cells is thus likely not 
suffi   cient to impede the promotion of the cell cycle induced by 
loss of Fbxw7 but may partially antagonize the uncontrolled 
proliferation that leads to tumor formation. 
  How does the loss of Fbxw7 function result in cancer de-
velopment? Dysregulation of cyclin E is a potential contribu-
tor to tumorigenesis in Fbxw7-defi  cient cells, given that 
increased levels of cyclin E have been associated with a vari-
ety of malignancies and that constitutive expression of cyclin E 
results in genomic instability (  37  ). Furthermore, RNA in-
terference  –  mediated depletion of cyclin E in cancer cell lines 
in which   Fbxw7   is also disrupted resulted in a marked de-
crease in the extent of chromosomal instability (  36  ). How-
ever, expression of cyclin E is not always increased in cancer 
cells in which   Fbxw7   is mutated (unpublished data) (  8, 31  ). 
In addition, expression of cyclin E is unaff  ected in   Fbxw7    –  /  –      
embryos (  10  ), although it is increased in the placenta of these 
embryos (  11  ). Furthermore, although the frequency of radia-
tion-induced lymphomas is increased in   Fbxw7  +/  –      mice, the 
abundance of cyclin E is not increased in these tumors (  8  ). 
In the present study, the abundance of cyclin E was not af-
fected in Fbxw7-defi  cient T cells. Collectively, these various 
observations suggest that accumulation of cyclin E in response 
to a loss of Fbxw7 is not a major cause of carcinogenesis. Whereas 
acute inactivation of Fbxw7 by RNA interference results in 
an increase in the level of cyclin E in many cell lines (unpub-
lished data) (  4, 31, 36, 38  ), such an acute eff  ect of loss of Fbxw7 
may be compensated for during development. It therefore 
seems likely that Fbxw7 contributes to cyclin E proteolysis in 
a context-dependent manner. 
  Another important substrate of Fbxw7 whose dysregula-
tion might be responsible for cancer development is c-Myc. 
Deregulated expression of Myc family genes is a common 
feature of a wide variety of malignancies, including T cell 
lymphomas. Indeed, T cells appear to be especially sensitive 
to Myc-dependent tumorigenesis, given that T cell lym-
phoma is the predominant tumor type in transgenic mice that 
overexpress c-Myc in hematopoietic progenitor cells (  39, 40  ). 
Previous transgenic animal studies have revealed frequent 
inactivating mutations of   p53   in Myc-induced lymphomas 
(  21, 23  ). Likewise, Myc-dependent T cell lymphomagenesis is 
accelerated by events that abrogate Myc-induced apoptosis, 
such as disruption of p53 pathway function (  41, 42  ). The syn-
ergy between Fbxw7- and p53-null genotypes in the develop-
ment of mouse thymic lymphomas detected in the present 
study is reminiscent of the observation that mice harboring a 
CD2-Myc transgene and a homozygous p53-null mutation 
(  p53    –  /  –     /CD2-myc) develop thymic lymphomas with a greatly 
increased frequency and reduced latency compared with both 
parental mice (  41  ). Although we did not detect an increase in 
from DP cells. This scenario is consistent with the decrease in 
the percentage as well as in the number of splenic T cells in 
Fbxw7-defi  cient mice. Such increased apoptosis in SP cells 
would likely be attributable to the induction of p53 in re-
sponse to c-Myc accumulation, as was apparent in splenic T 
cells of the mutant mice. 
  In addition to its role in the cell cycle, c-Myc contributes 
to the regulation of apoptosis, as has been revealed by studies 
of various cell types under a wide variety of physiological 
conditions, with both under- and overexpression of c-Myc 
having been found to result in cell death (  20  ). c-Myc induces 
apoptosis through at least two distinct pathways (  21  ). First, it 
induces the expression of p19  ARF  , an inhibitor of the ubiqui-
tin ligase MDM2, resulting in the stabilization of p53 (  22  ). 
Ablation of either p19  ARF   or p53 allows c-Myc to immortal-
ize primary cells and greatly facilitates c-Myc  –  induced lym-
phomagenesis (  23  ). However, the p19  ARF   gene does not appear 
to be a direct target of c-Myc, and the mechanism through 
which c-Myc activates p19  ARF   expression is unclear. The 
p19  ARF   gene is regulated directly by E2F transcription factors 
that function downstream of c-Myc. Whether c-Myc induces 
the expression of p19  ARF   by increasing the activity of E2F1 is 
controversial and may be dependent on cell type (  24, 25  ). 
Second, c-Myc promotes the release of cytochrome c from 
mitochondria in a p19  ARF  - and p53-independent manner 
(  26  ), and this eff  ect is mediated in part by the BH3-only pro-
tein Bim, whose expression is induced by c-Myc (  27  ); again, 
the induction of Bim expression by c-Myc is probably not a 
direct eff  ect. The roles of c-Myc in both the cell cycle and apop-
tosis are thus dependent, at least in part, on p53. The opposite 
phenotypes of immature and mature Fbxw7-defi  cient T cells 
are therefore likely attributable to c-Myc accumulation and 
diff  erential induction of p53. 
  The factors that determine whether a cell divides or dies 
warrant further investigation. We have shown that the re-
sponse to Fbxw7 loss is substantially changed between the 
DP and SP stages of T cell development. The expression of 
many sets of genes associated with cell proliferation, survival, 
migration, or maturation, as well as with allelic exclusion or 
lineage commitment, changes markedly during positive se-
lection of T cells (  28, 29  ). These changes in gene expression 
are controlled by transcription factors responsive to specifi  c 
signals in immature thymocytes. Although recent studies 
have implicated a small number of transcription factors in the 
regulation of gene expression during positive selection (  28  ), 
the mechanism by which the accumulation of c-Myc induces 
the expression of p53 in Fbxw7-defi  cient T cells remains to 
be determined. 
  Given that Fbxw7 is responsible for the degradation of 
c-Myc and other oncoproteins, it is thought to function as a 
tumor suppressor. Indeed, mutations in   FBXW7   have been 
detected in certain human malignancies (  30  –  36  ). In addition, 
  Fbxw7  +/  –      mice manifest an increased susceptibility to radiation-
induced tumorigenesis, although most of the induced tumors 
retain and express the wild-type allele, indicating that   Fbxw7   
is a haploinsuffi   cient tumor suppressor gene (  8  ). We have now 2886 FAILURE OF CELL-CYCLE EXIT IN   FBXW7   − / −     THYMOCYTES | Onoyama et al.
(RM4-5; all were obtained from BD Biosciences). For determination of 
BrdU incorporation in vivo, mice were administered two 1-mg intraperito-
neal injections of BrdU with a 2-h interval. The thymus was removed 1 h 
after the second injection, and BrdU incorporation was evaluated with a 
BrdU fl  ow kit (Becton Dickinson). All analyses were performed with FACS-
Calibur or FACSAria instruments (Becton Dickinson). 
  RT and real-time PCR analysis.     Total RNA was extracted from thymo-
cytes or stimulated splenic T cells by the guanidinium thiocyanate  –  phe-
nol-chloroform method, purifi  ed, and subjected (1     g) to complementary 
DNA (cDNA) synthesis with random hexanucleotide primers (ReverTra 
Ace     ; Toyobo). The cDNA was added to a quantitative PCR mixture 
that contained 1  ×   SYBR green PCR Master Mix (Applied Biosystems) 
and 200 nM of gene-specifi  c primers. Assays were performed in trip-
licate with a sequence detector (ABI Prism 7700; Applied Biosystems). 
The PCR protocol included incubation at 60  °  C for 30 s and 95  °  C 
for 5 s, followed by 40 cycles. The sequences of PCR primers were as 
follows: 5    -GGACCCGAGAAGACCTCCTT-3     (sense) and 5    -GCA-
CATCACTCAGAATTTCAATGG-3     (antisense) for acidic ribosomal 
phosphoprotein P0 (ARBP; a gift from Y. Ishikawa, Tohoku University, 
Sendai, Japan); 5    -GCCTGGAGAAACCTGCCAAGTATG-3     (sense) and 
5    -GAGTGGGAGTTGCTGTTGAAGTCG-3     (antisense) for GAPDH; 
5    -TGCAAAGTCTCAGATTATACC-3     (sense) and 5   -ACTTCTCTGG-
TCCGCTCCAGC-3     (antisense) for Fbxw7; 5    -TGTCTGAGCGGCCT-
GAAGATTC-3     (sense) and 5    -GCAGAAGACCAATCTGCGCTTG-3     
(antisense) for p21; 5   -TTTCATCCAGGATCGAGCAGGG-3     (sense) and 
5    -GTCCAGTTCATCTCCAATTCGCC-3     (antisense) for Bax; and 
5    -ACTCAGGAAGATCGGAGACAAAGTG-3     (sense) and 5   -ACACTC-
GTCCTTCAAGTCTGCTGG-3     (antisense) for Noxa. Primers for p21, 
Bax, and Noxa were gifts from M. Nishiyama (Kyushu University, Fukuoka, 
Japan). Reactions for ARBP or GAPDH mRNAs were performed concur-
rently on the same plate as those for the test mRNAs, and results were nor-
malized by the corresponding amounts of ARBP or GAPDH mRNAs. 
  Immunoblot analysis.     Total protein extracts were prepared from thymo-
cytes or splenic T cells of 8-wk-old mice with radioimmunoprecipitation buff  er. 
The 30-    g protein extracts were subjected to immunoblot analysis, as previously 
described (  53  ), with anti-Notch3 (M-20), anti  –  c-Myc (N-262), anti  –  cyclin E 
(M-20), anti  –  cyclin A (H-432), or anti-p53 (Pab240; all obtained from 
Santa Cruz Biotechnology, Inc.); anti  –  cleaved Notch1 (Val  1744  ), anti  –  Ser  63  -
phosphorylated c-Jun II, anti-JNK, anti  –  phospho-JNK (Thr  183  , Tyr  185  ), anti-
ERK (p44/42 mitogen-activated protein kinase), or anti  –  phospho-ERK 
(Thr  202  , Tyr  204  ; all obtained from Cell Signaling Technology); anti  –  Aurora A, 
anti  –  phospho-Lck (Tyr  505  ), or anti-p27 (all obtained from BD Biosciences); or 
anti-Lck (3A5; Sigma-Aldrich). As a control, each membrane was stripped and 
probed with anti-Hsp70 or anti-Hsp90 (BD Biosciences). 
  Confi  rmation of clonal expansion by Southern blot analysis.     The ge-
nomic DNA prepared from normal thymocytes or thymic lymphoma cells 
was digested with BamHI and probed with a 2.1-kb EcoRI fragment of the 
TCR-J    2 locus (a gift from T. Sato, Tokai University, Isehara, Japan). 
  T cell proliferation assay.     Splenic T cells were purifi  ed to     90% homo-
geneity from 8-wk-old mice with the use of a T cell enrich column (R  &  D 
Systems). 10  5   purifi  ed T cells were stimulated in triplicate with plate-bound 
anti-CD3     (145-2C11) at various concentrations in 96-well plates contain-
ing RPMI 1640 medium supplemented with 10% FBS. The cells were stim-
ulated for 48 h and exposed to 0.5     Ci [  3  H]thymidine per well for the fi  nal 
6 h of incubation, after which the incorporation of [  3  H]thymidine was mea-
sured with a scintillation counter (1205 Betaplate; Wallac). In other experi-
ments, the cells were incubated with 10     M BrdU for the last 1 h and 
stained with FITC-labeled anti-BrdU (BD Biosciences). 
  Transplantation experiments.     5   ×   10  6   lymphoma cells were collected, 
resuspended in PBS, and injected intraperitoneally into nude mice in a total 
p53 abundance in Fbxw7-null thymocytes, p53 may still play a 
role in antagonizing tumorigenesis in Fbxw7-defi  cient mice. 
  In contrast to T cells with an excess of c-Myc, those that 
lack c-Myc exhibit a pronounced proliferative defect (  43, 44  ) 
and fail to develop beyond the DN stage (  14  ). This inability of 
c-Myc  –  defi  cient T cells to diff  erentiate into DP thymocytes 
may refl  ect an important role for c-Myc in proliferation 
mediated by pre-TCR signaling (  45  ). Furthermore, the ex-
pression of c-Myc is down-regulated, possibly by a dedicated 
pathway, in naive quiescent peripheral T cells (  46  ) and is sub-
sequently up-regulated during the proliferative response to 
antigen-mediated TCR activation (  47  ). Our data now dem-
onstrate a physiological role for a ubiquitin ligase in cell-cycle 
exit during diff  erentiation, providing the basis for a new par-
adigm in the relation between cell proliferation and diff  eren-
tiation at the molecular level. 
  MATERIALS AND METHODS 
  Construction of a targeting vector and generation of mice with a 
fl  oxed   Fbxw7   allele.     Cloned genomic DNA corresponding to the   Fbxw7   
locus was previously isolated from a 129/Sv mouse genomic library (Strata-
gene). The 5     and 3     regions of homology in the targeting vector composed 
a 1.2-kb fragment of the fourth intron generated by PCR with the appropri-
ate primers and an 8-kb DraI-XhoI fragment spanning the fourth and ninth 
introns, respectively. The neomycin resistance gene (  neo  ) fl  anked by loxP 
sites was isolated from the plasmid pL2-Neo(2) (a gift from D.R. Littman, 
New York University, New York, NY) (  48  ) and inserted into the DraI site 
upstream of the fi  fth exon of   Fbxw7  . A loxP site was also inserted into the 
HpaI site downstream of the fi  fth exon. The PGK-tk-poly(A) cassette (a gift 
from D.R. Littman) was ligated at the 3     end of the targeting construct. The 
maintenance, transfection, and selection of ES cells were performed as previ-
ously described (  49, 50  ). The recombination event was confi  rmed by Southern 
blot analysis with a probe (probe 1) located outside of the 5     homology 
region (  Fig. 1 B   and Fig. S1). ES clones that had undergone homologous re-
combination were transfected with 30   μ  g pMC-Cre (a gift from D.R. Littman) 
to excise the loxP-  neo   cassette. Colonies were screened for acquired sensitiv-
ity to G418, and loss of the cassette was confi  rmed by Southern blot analysis 
with probe 2 (  Fig. 1 B  ). ES clones were injected into C57BL/6 mouse blasto-
cysts to generate chimeric mice. Germline transmission of the fl  oxed   Fbxw7   
allele was achieved by crossing chimeras with C57BL/6 mice and was con-
fi  rmed by Southern blot analysis of tail DNA with probe 2. Heterozygous 
off  spring were intercrossed to produce homozygous mutant animals. All 
mouse experiments were approved by the animal ethics committee of 
Kyushu University. 
  Generation of conditional knockout mice.     Mice homozygous for the 
fl  oxed   Fbxw7   allele (  Fbxw7  F/F    ) were crossed with Lck-Cre (  51  ) or CD4-Cre 
(a gift from C.B. Wilson, University of Washington, Seattle, WA) (  52  ) trans-
genic mice. Deletion of exon 5 of the fl  oxed   Fbxw7   allele was detected by 
PCR with the primers Floxed 1 (5    -CCTATAGGGAATTATGTTATTT-3    ) 
and Floxed 2 (5    -CTCACAGCCAAGTTATTCTGTT-3    ).   Fbxw7  F/F     mice 
were also crossed with   RBP-J  F/F     mice (a gift from T. Honjo, Kyoto University, 
Kyoto, Japan) (  13  ),   c-Myc  F/F     mice (  17  ), or   p53    –  /  –      mice (Taconic). All animal 
experiments were performed with littermates of a mixed genetic background. 
  Flow cytometry and antibodies.     The following monoclonal antibodies 
were used: FITC-conjugated anti-CD3     (145-2C11), anti-CD4 (RM4-5), 
anti-CD8     (53-6.7), anti-TCR     (H57-597), anti-B220 (RA3-6B2), and 
anti-CD69 (H1.2F3); PE-conjugated anti-CD8     (53-6.7); PE- and Cy5-con-
jugated anti-CD3     (145-2C11), anti-CD4 (RM4-5), anti-CD8     (53-6.7), 
and anti-B220 (RA3-6B2); and allophycocyanin-conjugated anti-CD4 JEM VOL. 204, November 26, 2007 
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